Segments - by Product Type (Cow Milk-Based, Soy-Based, Protein Hydrolysate, Specialty Formula, Others), by Form (Powder, Liquid, Ready-to-Feed), by Distribution Channel (Supermarkets/Hypermarkets, Pharmacies/Drugstores, Online Stores, Specialty Stores, Others), by End User (0-6 Months, 6-12 Months, 1-2 Years)
This report is updated with the latest market data and insights as of June 2026. Base year: 2025 | Forecast period: 2026-2034
As per our latest research, the global infant formula market size reached USD 66.9 billion in 2025, reflecting robust demand across both developed and emerging economies. The market is expected to grow at a CAGR of 7.2% from 2026 to 2034, with the forecasted market value estimated to reach USD 125.6 billion by 2034. This dynamic expansion is driven by a combination of demographic shifts, increasing female workforce participation, and growing awareness about infant nutrition. The infant formula market continues to evolve rapidly in 2025, shaped by innovations in product formulation, evolving consumer preferences, and regulatory frameworks that emphasize safety and nutritional adequacy.
One of the primary growth factors for the infant formula market is the increasing number of working mothers globally. As more women join the workforce, the need for convenient and nutritionally balanced feeding alternatives has surged. Infant formula provides a practical solution for parents seeking to ensure their infants receive essential nutrients when breastfeeding is not possible or insufficient. This trend is particularly pronounced in urban areas where lifestyles are fast-paced and dual-income households are the norm. Manufacturers are responding by introducing advanced formulas that closely mimic the nutritional profile of breast milk, incorporating human milk oligosaccharides (HMOs), lactoferrin, and structured lipids, further fueling market expansion.
Another significant driver is the heightened awareness and education about infant health and nutrition. Governments and health organizations worldwide are launching campaigns to inform parents about the critical importance of early childhood nutrition. This has led to a surge in demand for specialized formulas tailored to address specific health concerns such as lactose intolerance, allergies, and digestive issues. The integration of functional ingredients like prebiotics, probiotics, and omega fatty acids is becoming increasingly common, as parents seek products that support immune health and cognitive development. These innovations are setting new standards in the infant formula market, encouraging premiumization and product differentiation across all major geographies.
Demographic changes, particularly in emerging economies, are also propelling the infant formula market forward through 2025 and beyond. Rapid urbanization, rising disposable incomes, and changing family structures are contributing to higher adoption rates of infant formula products in countries such as China, India, and Brazil. These regions are witnessing a shift from traditional feeding practices to modern, science-backed alternatives. Multinational companies are expanding their footprint in these high-growth markets, often through partnerships and localized product offerings. As a result, the infant formula market is becoming increasingly globalized, with cross-border investments and supply chain enhancements playing a pivotal role in meeting rising demand.
Regionally, Asia Pacific remains the largest and fastest-growing market for infant formula, accounting for over 45% of global sales in 2025. This dominance is underpinned by large birth cohorts, rising health consciousness, and a strong preference for premium imported brands in countries like China. North America and Europe continue to demonstrate steady growth, driven by innovation and stringent regulatory standards. Meanwhile, Latin America and the Middle East & Africa are emerging as promising markets, supported by improving healthcare infrastructure and increasing consumer awareness. The competitive landscape is marked by the presence of major multinational players as well as regional brands catering to local needs and preferences.
In recent years, there has been a growing interest in plant-based infant formula alternatives as a complement to traditional dairy-based products. This shift is driven by increasing consumer awareness of plant-based diets and their potential health benefits, as well as concerns about allergies and lactose intolerance in infants. Plant-based formulas, often derived from soy, almond, or rice, offer a viable option for parents seeking to provide their infants with essential nutrients without relying on animal products. As this trend gains momentum through 2025, manufacturers are investing in research and development to enhance the taste, texture, and nutritional profile of these innovative products, positioning them as a growing segment within the broader infant formula market.
The infant formula market is segmented by product type into cow milk-based, soy-based, protein hydrolysate, specialty formula, and others. Cow milk-based formulas remain the dominant category, accounting for approximately 52% of global market share in 2025, due to their nutritional adequacy and widespread acceptance among parents and healthcare professionals. These formulas are designed to closely replicate the composition of human breast milk, providing essential proteins, carbohydrates, fats, vitamins, and minerals in proportions suitable for infant growth and development. The continuous improvement in cow milk-based product formulation, including the addition of HMOs, prebiotics, and other functional ingredients, has helped maintain their popularity and drive sustained market growth through the forecast period.
Soy-based formulas represent a significant segment, accounting for approximately 14.5% of the market in 2025, particularly for infants who are lactose intolerant or allergic to cow's milk protein. These formulas are derived from soy protein isolates and are fortified with essential nutrients to support healthy growth. The demand for soy-based formulas is also influenced by the growing trend toward plant-based nutrition and the increasing prevalence of dietary restrictions among infants. However, their adoption is somewhat limited by concerns regarding phytoestrogens and the potential for allergenicity, prompting ongoing research and development to enhance their safety and efficacy. Manufacturers are also exploring other plant-derived sources to broaden the appeal of this segment.
Protein hydrolysate formulas are gaining traction, capturing around 13.5% of the global market in 2025, as they cater to infants with specific digestive or allergic conditions. These formulas are created by breaking down proteins into smaller, more easily digestible peptides, making them suitable for infants with cow's milk protein allergy or malabsorption issues. The segment is witnessing robust growth, supported by increasing pediatric recommendations and a rising incidence of food allergies among infants. Manufacturers are investing in clinical research to validate the benefits of hydrolyzed formulas, leading to greater acceptance among healthcare providers and parents alike during the 2026-2034 forecast period.
Specialty formulas constitute a niche but rapidly expanding segment, holding roughly 12% of global market share in 2025. These products are formulated for infants with unique medical or nutritional needs, such as metabolic disorders, premature birth, or gastrointestinal complications. The development of specialty formulas requires advanced research and close collaboration with medical professionals to ensure efficacy and safety. As awareness of rare pediatric conditions grows and diagnostic capabilities improve, the demand for specialty formulas is expected to rise considerably through 2034. Other product types, including organic and goat milk-based formulas, collectively accounting for around 8% of the market, are also gaining popularity as parents seek natural and alternative options for infant nutrition.
| Attributes | Details |
| Report Title | Infant Formula Market Research Report 2034 |
| By Product Type | Cow Milk-Based, Soy-Based, Protein Hydrolysate, Specialty Formula, Others |
| By Form | Powder, Liquid, Ready-to-Feed |
| By Distribution Channel | Supermarkets/Hypermarkets, Pharmacies/Drugstores, Online Stores, Specialty Stores, Others |
| By End User | 0-6 Months, 6-12 Months, 1-2 Years |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2025 |
| Historic Data | 2019-2024 |
| Forecast Period | 2026-2034 |
| Number of Pages | 251 |
| Number of Tables & Figures | 294 |
| Customization Available | Yes, the report can be customized as per your need. |
The infant formula market can be segmented by form into powder, liquid, and ready-to-feed formulas. Powdered formulas dominate the market, accounting for the majority of sales in 2025 due to their cost-effectiveness, longer shelf life, and ease of storage and transportation. Powdered formulas are preferred by both consumers and retailers, as they offer flexibility in preparation and can be easily measured to suit individual feeding requirements. Manufacturers have focused on improving the solubility and texture of powdered formulas, ensuring they mix easily and maintain nutritional integrity. This segment is expected to continue its strong growth trajectory through 2034, particularly in price-sensitive and high-volume markets across Asia Pacific and Latin America.
Liquid formulas, available as concentrated liquids, represent a smaller but significant segment. These products offer the advantage of convenience, as they require less preparation time compared to powdered formulas. Liquid concentrates are often chosen by parents seeking a balance between convenience and cost, as they are typically less expensive than ready-to-feed formulas but more convenient than powders. The liquid formula segment is witnessing innovation in packaging, with the introduction of single-serve containers and resealable bottles to enhance usability and reduce wastage across markets in North America and Europe.
The demand for ready-to-feed infant formula options is on the rise in 2025, particularly among urban consumers and parents with hectic lifestyles. These formulas offer unparalleled convenience, as they require no preparation or mixing, making them an ideal choice for on-the-go feeding. Ready-to-feed options are also favored in hospital settings due to their sterility and ease of use, providing a reliable solution for newborns and premature infants. Despite their higher cost compared to powdered or liquid concentrates, the growing emphasis on convenience and time-saving solutions is driving the popularity of this format steadily toward 2034. Manufacturers are responding by introducing innovative packaging solutions, such as single-serve containers and resealable bottles, to enhance usability and reduce wastage.
The form factor of infant formula plays a crucial role in influencing consumer purchasing decisions. Factors such as lifestyle, income levels, and access to clean water significantly impact the choice of formula form. In developed markets, the demand for ready-to-feed and liquid formulas is higher, reflecting a willingness to pay a premium for convenience. Conversely, in emerging economies, powdered formulas remain the preferred choice due to affordability and availability. Manufacturers are continuously innovating in packaging and formulation to cater to diverse consumer needs and enhance the overall feeding experience across the 2026-2034 forecast window.
Distribution channels for infant formula include supermarkets/hypermarkets, pharmacies/drugstores, online stores, specialty stores, and others. Supermarkets and hypermarkets represent the largest distribution channel, accounting for a significant share of market sales in 2025. These retail outlets offer a wide range of products, competitive pricing, and the convenience of one-stop shopping, making them the preferred choice for many consumers. The presence of dedicated baby care sections and regular promotional activities further boost sales through this channel. Retailers are also leveraging loyalty programs and in-store consultations to enhance customer engagement and drive repeat purchases throughout the forecast period.
Pharmacies and drugstores are another critical distribution channel, particularly for specialty and medically prescribed formulas. These outlets are trusted by parents for their association with healthcare professionals and their ability to provide expert advice on product selection. Pharmacies often stock a curated range of infant formulas, including hypoallergenic and specialty products, catering to infants with specific health needs. The growing trend of pharmacy chains expanding their baby care offerings is contributing to the growth of this channel, especially in urban and semi-urban areas across Europe and North America.
Online stores are rapidly gaining prominence as a distribution channel for infant formula in 2025, driven by the increasing penetration of e-commerce and changing shopping habits. The convenience of home delivery, access to a wide variety of brands, and the ability to compare prices and read reviews are key factors driving online sales. E-commerce platforms are also offering subscription services and discounts, encouraging repeat purchases and brand loyalty. The post-pandemic consumer shift toward digital purchasing has become entrenched, with many parents opting for contactless and convenient online options to ensure timely supply of infant nutrition products.
Specialty stores, including dedicated baby care outlets and organic or natural product retailers, are emerging as important channels for premium and niche infant formula products. These stores focus on providing personalized service, expert advice, and a curated selection of high-quality products. Parents seeking organic, non-GMO, or allergen-free formulas often prefer specialty stores for their specialized offerings and knowledgeable staff. Other distribution channels, such as direct sales and hospital supply, also play a role in certain markets, particularly for specialty and prescription formulas targeting clinical settings.
The market for certified organic infant formulas is gaining traction as parents increasingly prioritize natural and chemical-free options in 2025. This segment is driven by growing awareness of the potential health benefits associated with organic products, as well as concerns about pesticides and synthetic additives in conventional formulas. Organic formulas are produced using ingredients free from genetically modified organisms (GMOs) and artificial preservatives, aligning with the preferences of health-conscious consumers. As the demand for organic products continues to rise toward 2034, companies are investing in expanding their organic product lines and enhancing their supply chains to meet consumer expectations, reflecting a broader movement toward sustainability and transparency in the infant formula industry.
The end-user segmentation of the infant formula market encompasses three age groups: 0-6 months, 6-12 months, and 1-2 years. The 0-6 months segment holds the largest share in 2025, as this is the critical period where exclusive breastfeeding or formula feeding is recommended for optimal growth and development. Infant formulas designed for this age group are formulated to closely mimic the nutritional composition of breast milk, providing essential nutrients required for rapid physical and cognitive development. The segment's dominance is underpinned by strong recommendations from healthcare professionals and regulatory guidelines emphasizing the importance of adequate nutrition in the first six months of life.
The 6-12 months segment represents a significant portion of the market, as infants begin to transition to complementary foods while continuing to rely on formula for their nutritional needs. Formulas targeted at this age group are often enriched with additional nutrients such as iron, calcium, and vitamins to support the developmental milestones associated with this stage. The demand for follow-on formulas is rising steadily through 2025, driven by parental concerns about maintaining balanced nutrition during the weaning process. Manufacturers are introducing products with added functional ingredients to support digestive health, immunity, and cognitive development, catering to the evolving needs of infants and parents in both developed and emerging markets.
The 1-2 years segment, though smaller in comparison, is gaining traction as parents increasingly seek toddler-specific formulas to support continued growth and development through the 2026-2034 forecast period. These products are fortified with nutrients that address the specific needs of toddlers, such as higher levels of protein, calcium, and DHA. The growing awareness of the importance of nutrition beyond infancy is fueling demand for toddler formulas, particularly in markets where dietary diversity may be limited. Manufacturers are responding by expanding their product portfolios to include age-specific formulas that cater to the unique requirements of older infants and young children.
The segmentation by end user highlights the evolving nature of the infant formula market, with manufacturers focusing on developing targeted products that address the changing nutritional needs of infants at different stages of growth. This approach not only enhances product efficacy but also allows companies to capture a larger share of the market by catering to a broader age range. The increasing emphasis on scientific research and clinical validation is further driving innovation in this segment, ensuring that products meet the highest standards of safety and nutritional adequacy through 2034.
The infant formula market presents substantial opportunities for growth and innovation in 2025, particularly in emerging economies where rising disposable incomes and changing lifestyles are driving demand for premium and specialized products. The increasing prevalence of food allergies and intolerances among infants has created a lucrative market for hypoallergenic and specialty formulas. Advances in nutritional science and biotechnology are enabling the development of next-generation formulas that closely replicate the bioactive components of human breast milk, such as HMOs, lactoferrin, and probiotics. These innovations are not only enhancing the nutritional value of infant formulas but also providing a competitive edge to manufacturers willing to invest in research and development. Strategic partnerships, mergers, and acquisitions are further enabling companies to expand their product portfolios and geographic reach, creating new avenues for growth in the global infant formula market through 2034.
Digital transformation and the rise of e-commerce present another significant opportunity for market expansion. Online platforms are making it easier for parents to access a wide range of infant formula products, compare prices, and read reviews, thereby increasing transparency and consumer empowerment. The adoption of digital marketing strategies, including social media campaigns and influencer partnerships, is helping brands reach and engage with tech-savvy millennial and Gen Z parents. Subscription-based models and direct-to-consumer sales are gaining popularity, providing companies with recurring revenue streams and valuable consumer insights. As the digital landscape continues to evolve toward 2034, companies that leverage technology to enhance the customer experience and streamline supply chains are positioned to gain a meaningful competitive advantage in the infant formula market.
Despite these opportunities, the infant formula market faces several restraining factors, the most significant of which is the increasing emphasis on breastfeeding promotion by governments and health organizations. The World Health Organization (WHO) and UNICEF strongly advocate exclusive breastfeeding for the first six months of life, citing its numerous health benefits for both infants and mothers. This has led to the implementation of stringent regulations and marketing restrictions on infant formula products in many countries, particularly regarding advertising and labeling under the International Code of Marketing of Breast-milk Substitutes. Additionally, concerns about product safety, contamination, and the environmental impact of formula production and packaging are prompting greater scrutiny from regulators and consumers alike. Supply chain vulnerabilities, highlighted by the U.S. formula shortage of 2022, remain a structural risk that companies must address through diversified sourcing and domestic production investment. Companies must navigate these challenges by ensuring compliance with regulatory standards, investing in sustainable practices, and prioritizing transparency and consumer trust throughout the forecast period.
The Asia Pacific region remains the largest and most dynamic market for infant formula, accounting for approximately USD 30.4 billion in 2025. This dominance is driven by high birth rates, rising urbanization, and increasing disposable incomes in countries such as China, India, and Indonesia. China represents the single largest market globally, with a strong preference for premium and imported brands alongside a rapidly expanding middle class. The region is also witnessing a shift toward specialized and organic formulas, reflecting growing health consciousness among parents. The Asia Pacific market is projected to grow at a CAGR of 8.1% through 2034, outpacing other regions and offering significant opportunities for both global and local manufacturers across the forecast window.
In North America, the infant formula market was valued at approximately USD 13.0 billion in 2025, characterized by high standards of product safety, innovation, and regulatory oversight. The market is driven by steady birth rates, increasing female workforce participation, and a strong focus on premium and specialty products. The United States remains the largest market in the region, with a well-developed distribution network and a high level of consumer awareness regarding infant nutrition. Lessons learned from the 2022 supply shortage have prompted significant investment in domestic manufacturing capacity, improving market resilience. The trend toward organic and non-GMO formulas is gaining momentum, supported by a growing segment of health-conscious parents. North America is expected to maintain steady growth, with a projected CAGR of 5.9% through 2034.
Europe accounted for approximately USD 10.7 billion in 2025, with market growth fueled by stringent regulatory standards, a high degree of product innovation, and increasing demand for organic and specialty formulas. The region is characterized by a mature market structure, with established brands and a strong emphasis on sustainability and ethical sourcing. Countries such as Germany, France, and the United Kingdom are leading the adoption of advanced formulations and eco-friendly packaging. Meanwhile, Latin America and the Middle East & Africa regions are emerging as promising markets, with a combined market value of approximately USD 12.8 billion in 2025. These regions are benefiting from improving healthcare infrastructure, rising birth rates, and increasing consumer awareness, though growth is moderated by economic and regulatory challenges. Overall, the regional outlook for the infant formula market is positive through 2034, with ample opportunities for expansion and innovation across diverse geographies.
The infant formula market in 2025 is highly competitive, with the presence of both global giants and regional players vying for market share. The landscape is characterized by intense rivalry, continuous product innovation, and significant investments in research and development. Leading companies are focusing on developing advanced formulations that closely mimic the nutritional profile of human breast milk, incorporating functional ingredients such as prebiotics, probiotics, and HMOs. The competitive environment is further shaped by regulatory requirements, with companies striving to ensure product safety, quality, and compliance with local and international standards. The ability to innovate and adapt to changing consumer preferences is a key determinant of success in this dynamic market through the 2026-2034 forecast period.
Mergers, acquisitions, and strategic partnerships are common strategies employed by major players to expand their product portfolios and geographic reach. Companies are increasingly investing in emerging markets, where rising incomes and changing lifestyles are driving demand for premium and specialized infant formula products. The entry of new players, particularly in the organic and plant-based segments, is intensifying competition and fostering innovation. Digital transformation is also playing a pivotal role, with companies leveraging e-commerce platforms, data analytics, and digital marketing to enhance customer engagement and streamline operations. Direct-to-consumer brands, such as Bobbie Inc. in North America, are disrupting traditional distribution models by emphasizing transparency and clean-label formulations.
Brand reputation and consumer trust are critical factors in the infant formula market, given the sensitive nature of the product and the high level of scrutiny from regulators and health organizations. Companies are investing heavily in quality assurance, traceability, and transparency initiatives to build and maintain consumer confidence. Sustainability is also emerging as a key differentiator, with leading brands adopting eco-friendly packaging, responsible sourcing, and waste reduction initiatives. The focus on corporate social responsibility and ethical practices is becoming increasingly important as consumers seek brands that align with their values and priorities in 2025 and beyond.
The market is led by several major companies, including Nestlé S.A., Danone S.A., Abbott Laboratories, Reckitt Benckiser Group plc (Mead Johnson Nutrition), and FrieslandCampina. Nestlé, with its wide range of infant nutrition products spanning NAN, Gerber, and Illuma, continues to lead the global market. Danone is recognized for its focus on innovation and sustainability, with a strong portfolio of specialized and organic formulas under the Aptamil and Nutrilon brands. Abbott Laboratories is known for its emphasis on scientific research and clinical validation, while Reckitt Benckiser's Mead Johnson (Enfamil) has a long-standing reputation for quality and safety. FrieslandCampina is expanding its footprint in Asia and other emerging markets through strategic partnerships and product innovation.
Other notable players include Arla Foods amba, Meiji Holdings Co., Ltd., China Feihe Limited, Bellamy's Organic (China Mengniu Dairy), and Ausnutria Dairy Corporation Ltd.. These companies are focusing on niche segments such as organic, goat milk-based, and plant-based formulas to differentiate themselves in a crowded market. Emerging domestic brands in China, such as Yili Group and Beingmate, are gaining market share by leveraging local consumer trust and government support for domestic dairy products. The competitive landscape is expected to remain dynamic through 2034, with ongoing investments in research, innovation, and sustainability shaping the future of the global infant formula market.
The Infant Formula market has been segmented on the basis of
The global infant formula market is led by Nestlé S.A., whose NAN, Gerber, and Illuma brands maintain a broad international presence. Danone S.A. (Aptamil, Nutrilon, Karicare) is a strong second, recognized for innovation and sustainability. Abbott Laboratories (Similac) and Reckitt Benckiser's Mead Johnson (Enfamil) are dominant in North America. China Feihe Limited and Yili Group are leading domestic players in China. Other key competitors include FrieslandCampina, Meiji Holdings, Arla Foods, Ausnutria Dairy, Morinaga Milk Industry, Holle baby food, and Bellamy's Organic (now part of China Mengniu Dairy).
The infant formula market faces several significant challenges. Breastfeeding promotion campaigns by the WHO, UNICEF, and national health bodies place regulatory and reputational pressure on formula manufacturers, particularly regarding advertising restrictions governed by the International Code of Marketing of Breast-milk Substitutes. Product safety and contamination incidents have historically damaged consumer trust and triggered costly recalls. Supply chain vulnerabilities, highlighted by shortages in the United States in 2022, continue to underline the need for diversified sourcing. Stringent and evolving regulatory frameworks across markets add compliance complexity, while rising raw material and energy costs pressure margins.
Major trends include the premiumization of infant formula with advanced bioactive ingredients like HMOs, lactoferrin, and structured lipids; rapid growth in organic and clean-label products as health-conscious parents prioritize transparency; expansion of plant-based and goat milk-based alternatives; and digitalization of retail and marketing through e-commerce and influencer-driven campaigns. Key opportunities lie in underpenetrated emerging markets, innovations in hypoallergenic and specialty formulas, direct-to-consumer subscription models, and sustainable packaging initiatives that appeal to environmentally conscious millennial and Gen Z parents.
The infant formula market is divided into three primary end-user age groups. The 0-6 months segment holds the largest share, as this period is critical for exclusive formula or breastfeeding to support rapid physical and cognitive development. The 6-12 months segment is significant, with follow-on formulas enriched with iron, calcium, and vitamins supporting the transition to complementary foods. The 1-2 years segment, while smaller, is the fastest-growing, as parental awareness of toddler-specific nutritional needs rises and manufacturers expand age-targeted product portfolios.
Supermarkets and hypermarkets remain the dominant distribution channel in 2025, offering competitive pricing, broad product variety, and one-stop shopping convenience. Pharmacies and drugstores are critical for specialty and medically prescribed formulas, benefiting from consumer trust in healthcare-associated retail. Online stores are the fastest-growing channel, driven by e-commerce penetration, home delivery convenience, subscription models, and the ability to compare products. Specialty baby care stores cater to premium and niche segments, while hospital supply and direct-to-consumer channels serve specialized clinical needs.
Powdered infant formula is the most popular form, commanding the majority of global market sales in 2025. Its popularity stems from cost-effectiveness, longer shelf life, ease of storage, and flexibility in preparation. Liquid concentrate formulas occupy a smaller but notable segment valued for added convenience at a moderate price point. Ready-to-feed formulas are the fastest-growing form, particularly favored in urban markets and hospital settings for their unmatched convenience and sterility, despite carrying a higher price premium.
The infant formula market is segmented into five main product types. Cow milk-based formulas hold the largest share at around 52%, offering broad nutritional adequacy. Soy-based formulas, accounting for approximately 14.5%, cater to lactose-intolerant and plant-based diet-following families. Protein hydrolysate formulas (around 13.5%) serve infants with cow milk protein allergies or digestive issues. Specialty formulas (approximately 12%) address medical conditions such as metabolic disorders and premature birth. The remaining 8% includes goat milk-based, organic, and other emerging variants.
Asia Pacific leads the global infant formula market, accounting for approximately 45.5% of global revenue in 2025, valued at around USD 30.4 billion. This is driven primarily by China, India, and Indonesia, where high birth rates, rising incomes, and a preference for premium products are strong demand catalysts. North America ranks second, followed by Europe. Latin America and the Middle East & Africa are the fastest-developing emerging markets, supported by improving healthcare infrastructure and growing consumer awareness through the forecast period to 2034.
Key growth drivers include rising numbers of working mothers globally, which increases demand for convenient feeding alternatives; heightened parental awareness of infant nutrition; growing prevalence of food allergies and intolerances prompting demand for hypoallergenic and specialty products; rapid urbanization and rising disposable incomes in Asia Pacific, Latin America, and the Middle East; and ongoing innovations such as the inclusion of human milk oligosaccharides (HMOs), probiotics, and omega fatty acids in formulations.
The global infant formula market reached USD 66.9 billion in 2025, the base year for this study. It is projected to expand at a CAGR of 7.2% from 2026 to 2034, reaching an estimated USD 125.6 billion by 2034. Growth is supported by rising birth rates in emerging economies, increasing female workforce participation, and continuous product innovation across both standard and specialty formula categories.